Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema

NCT06179030 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi as lead sponsor.

NCT NCT06179030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06179030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema
Lead sponsor
Saglik Bilimleri Universitesi
Phase
Observational
Overall status
Completed
Start date
May 1, 2022
Completion date
October 17, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, inflammation